English
Analysis of value generation in the pharmaceutical subsector. Longitudinal study of value drivers811
Article Sidebar
Main Article Content
Abstract
The research analyzes the operational and financial decisions made in companies in the “pharmaceutical products, biotechnology and health sciences” subsector during the years 2019, 2020, 2021 and 2022, to determine which value drivers contributed to the generation of value. A descriptive, quantitative, longitudinal and correlational approach was used, with a sample of 30 companies listed on the Mexican Stock Exchange. EVA was evaluated as an indicator of value generation, and EBITDA Margin, PDC and Tax Shield, as value drivers.
The results revealed that the subsector experienced significant growth in income and profits during the period studied, especially in the biotechnology branch, which had the highest percentage increase. The pharmaceutical products sector showed the greatest generation of value, followed by health tools and services. The correlation analysis showed that PDC is more positively related to value generation in biotechnology, while EBITDA margin has a strong positive correlation in health tools and services. For the pharmaceutical products industry, none of the value drivers showed a strong relationship with value generation.
In conclusion, the subsector shows that companies had to adapt, take advantage of growth opportunities and manage their operations efficiently in the face of the atypical years of the period under study. The value drivers varied their impact depending on the industry, which suggests the importance of understanding the specific dynamics of each area in making operational and financial decisio
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
All articles published in the RECEIN Journal are under an open access policy and can be permanently free for everyone to read, download, copy and distribute according to the CC-BY license, except where otherwise noted.
References
Caro-Vargas, S. (2022). Posibilidades de IED desde India en el sector farmacéutico. Autora de capítulo. Caro-Vargas, S. y Restrepo-Rivillas, C.A. (2022). Editores. Atracción de inversión extranjera directa desde países emergentes. El caso de india y Colombia. Universidad de Extrenado: Colombia.
Copeland, T., Koller, T. y Murrin, J. (1994). Valuation: Measuring and managing the value of companies. 2nd edition. EUA: Wiley.
Deloitte (2020). 2020 Global Health Care Outlook, recuperado de https://www2.deloitte.com/es/es/pages/life-sciences-and-healthcare/articles/global-health-care-outlook-2020.html
Echeverry, H. (2006). ¿Es el EVA, realmente, un indicador del valor económico agregado? AD-MINISTER Universidad EAFIT, (9), 38-61.
Farouk, A., Othman, I., Emmanuel, A., Chileshe, N. y Kamil, M. (2021). Impact of value management on building projects sucess: structural equation model approach. Journal of Construction Engenieering and Management. 147(4). Doi.org/10.1061/(ASCE)CO.1943-7862.0002026
Jiménez, J. y Rojas, F. (2016). Aplicación de inductores generadores de valor para la gestión en microempresas. En Contexto, 4(5), 99-116.
Kampf, G., Todt, D., Pfaender, S., & Steinmann, E. (2020). Persistence of coronaviruses on inanimate surfaces andtheir inactivation with biocidal agent. Journal of Hospital Infection, 246-251. Doi:https://doi.org/10.1016/j.jhin.2020.01.022
Ledley, F.D., Shonka, S., Vaughan, G. y Galkina, E. (2020). Profitability of large pharmaceutical companies compared with other large public companies. Journal of the American Medical Association, 322(9), 834-843.
López-Rodríguez, C. E., Cardozo, C. E., Monroy, L. y González, E. G. (2019). El impacto del valor económico agregado (EVA) en la valoración accionaria de las empresas colombiana entre los años 2015 al 2018. Revista Espacios 40(43), 1-8.
Moreno, I. (2024). https://www2.deloitte.com/es/es/pages/life-sciences-and-healthcare/articles/inversion-inversion-y-desarrollo-sector-farmaceutico.html
Mosquera, A. y Cabezas, C. (2021). El efecto del escudo fiscal como determinante de la estructura de capital y la generación de valor: un análisis empírico en el mercado colombiano. Apuntes Contables, 28(4), 59-78.
Narea Chumbi, P.F. y Guamán Tenezaca, G.A. (2021). Aplicación de indicadores financieros e inductores de valor como herramienta de optimización de las decisiones estratégicas empresariales. Revista Economía y Política, 34(-), 94-111.
Orus, A. (2023). La industria farmacéutica en el mundo – datos estadísticos. Consultado de Statista, de https://es.statista.com/temas/11580/la-industria-farmaceutica-en-el-mundo/#topicOverview
Pinzón- Herrera, M., Sánchez-Piraban, E.M., Serrano-Serrat, L.V. y Guevara-Garzón, C.N. (2022). Análisis de inductores de valor operativo en empresas Sabana Centro en Cundinamarca, Colombia. Revista Universidad y Sociedad, 14(S1), 403-416.
Prem-Lal, J. y Tariq-H. I. (2023). Strategic management accounting and performance measurement systems. IK International Pvt: India.
Rojas, F.S. y Delgado, T. (2022). Diagnóstico del modelo de generación de valor como herramienta de gestión financiera en instituciones prestadoras de servicios de salud privadas de tercer nivel de complejidad en la ciudad de Medellín. Apuntes Contables, 29(-), 167-183.
Statista (2024) https://es.statista.com/temas/11580/la-industria-farmaceutica-en-el-mundo/#topicOverview
Smith, A. (2021). "Relevance of Value Management in Contemporary Business Practices." Journal of Financial Management, 42(3), 123-145.
Thakrar, N.T. (2020). An empirical study of profitability analysis of selected famacéutical Companies of India. International Journal of Research 8(9), 52-65.
Vera-Colina, M.A. (2000). EVA y CVA como medidas de la creación de valor en un negocio. Una introducción. Revista Tendencias, 1(1), 1-20.
Westreicher, G. y Sevilla-Arias, A. (2018). Escudo fiscal, recuperado de https://economipedia.com/definiciones/escudo-fiscal.html
Wogst, J., Tanikulova, P. y Lueg, R. (2023). Value-based management: a review of its conceptualizations and research agenda toward sustainable governance [manuescrito no publicado]. Journal of Accounting Literatura.